Closure of Trading Window for the quarter ended December 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Caprolactam Chemicals Ltd has informed BSE that the trading window for dealing in its securities by designated persons will remain closed from January 1, 2026 until 48 hours after the declaration of financial results for the quarter and half year ended December 31, 2025. This is a routine compliance measure taken under SEBI's Prohibition of Insider Trading Regulations, 2015, to prevent trading on unpublished price-sensitive information ahead of the quarterly results. The company has advised all designated persons not to trade in the stock during this window. The board meeting date to announce Q3 and H2 FY26 results is yet to be communicated and will be intimated separately.
This is a routine regulatory filing with no direct impact on shareholders or stock price. It signals that the Q3 FY26 results announcement is approaching, and retail investors can expect the results to be released within the next few weeks.